Project Grant R01DK144008
- The federal Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to address the challenges preventing the provision of guideline-recommended diabetes care in the United States. The overarching goals are to: Describe differences in diabetes care receipt across individual, neighborhood, and insurance characteristics. Examine differences in...
- This $161,664 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop "DREAM: BUILDING EQUITABLE PREDICTIVE MODELS FOR PERSONALIZED DIABETES PHARMACOTHERAPY." The project has three key objectives: (1) creating predictive models to estimate individualized outcomes like HbA1c, weight, and hypoglycemia for diabetes medication options,...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will evaluate an Adaptive Dietary Intervention (ADI) leveraging Continuous Glucose Monitoring (CGM) for Asian Americans with Type 2 Diabetes (T2D). The $970,016 grant, awarded on September 19, 2025, will be used by New York University (NYU) to examine the feasibility, acceptability, and effects of...
- This federal Project Grant award of $152,379.00, provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop an AI-based framework that can identify digital biomarkers of glycemic control and patient-reported outcomes for personalized diabetes management. The goal is to leverage physiological signals, glucose management data, and...
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $199,999 to the University of Florida to develop innovative artificial intelligence (AI)-based methods to support the discovery of potent, orally available small-molecule heparanase inhibitors. The goal is to evaluate these novel heparanase inhibitors in murine models as a...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $200,660 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Albert Einstein College of Medicine. The grant will fund the development and testing of a mobile health application for a digital mind-body intervention (DMBI) targeted at improving psychological distress and quality-of-life among Black and Hispanic patients with inflammatory bowel disease...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $762,556 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Aurora Health Care, Inc. The award supports the development of a novel, semi-automated self-monitoring feedback system for health promotion in community settings. The project aims to optimize the efficacy of feedback messages related to dietary intake, physical activity, and weight...
- This $802,363 federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a research study at Emory University from September 2025 to June 2030 to develop models for predicting the benefits of GLP-1 receptor agonist (GLP-1RA) treatments in preventing obesity-related cardiometabolic diseases. The study aims to use clinical...
- This Project Grant award from the National Science Foundation (NSF) under the Mathematical and Physical Sciences (CFDA 47.049) federal grant program aims to improve diabetes care through the development of personalized digital twin models. The $716,195 award to the Research Foundation for the State University of New York (RF SUNY) will fund the creation of virtual patient models that can learn from wearable health sensors and guide real-time insulin delivery using automated medical devices....
- This Project Grant award of $400,627.00, made on August 8, 2025 by the National Institute of Environmental Health Sciences under the Medical Library Assistance program (CFDA 93.879), aims to develop and test a "HealthCoach" chatbot in English and Spanish. The chatbot will help patients with varying literacy levels gain insights from their electronic health record notes and use this knowledge to prepare for their next medical visit. The award was made to Beth Israel Deaconess Medical...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $847,498 to New York University (NYU) to develop and test an AI-driven clinical decision support system (CDS) and chatbot for managing patients on incretin mimetic medications (IMMs) for obesity treatment. The goal is to increase patient adherence and reduce the burden on healthcare providers in managing these highly effective but administratively complex medications. The project, titled "AIMANAGE USING AN AI-DRIVEN CDS AND CHATBOT FOR THE MANAGEMENT OF PATIENTS ON INCRETIN MIMETIC MEDICATIONS", will run from August 2025 to May 2030, leveraging NYU's expertise in biomedical research, clinical studies, and specialized medical services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $847.5k | 8/11/25 |